Patents by Inventor J. Andrea McCart

J. Andrea McCart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell
    Patent number: 8506947
    Abstract: A composition of matter comprising a vaccinia virus expression vector with a negative thymidine kinase phenotype and a negative vaccinia virus growth factor phenotype.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: August 13, 2013
    Assignee: The United States of America as Represented by the Secretary of the Department of Health and Human Services
    Inventors: J. Andrea McCart, David L. Bartlett, Bernard Moss
  • Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
    Patent number: 7208313
    Abstract: A composition of matter comprising a vaccinia virus expression vector with a negative thymidine kinase phenotype and a negative vaccinia virus growth factor phenotype.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: April 24, 2007
    Assignee: United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: J. Andrea McCart, David L. Bartlett, Bernard Moss
  • Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
    Publication number: 20030031681
    Abstract: A composition of matter comprising a vaccinia virus expression vector with a negative thymidine kinase phenotype and a negative vaccinia virus growth factor phenotype.
    Type: Application
    Filed: November 13, 2001
    Publication date: February 13, 2003
    Inventors: J. Andrea McCart, David L. Bartlett, Bernard Moss